Slipped back into losses in 2Q21■ 1H21 results missed expectations as TCM slipped into core net loss in 2Q21due to unfavourable sales mix and higher opex incurred.■ The group expect a challenging 2H21F in view of economy uncertaintiesamidst rising positive Covid-19 cases in Malaysia and the IndoChina region.■ We cut FY21-23F EPS. Maintain Reduce with […]

Read more of this post